Largest Insider Trades of the Week

Insiders add to holdings of ADMA Biologics, dump shares of Evolus

Author's Avatar
May 24, 2019
Article's Main Image

The GuruFocus All-in-One Screener can be used to find insider trades from the past week. Under the insiders tab, change the settings for All Insider Buying to “$200,000+,” the duration to “May 2019” and All Insider Sales to “$200,000+.”

According to these filters, the following are trades from company insiders this week.

Perceptive Life Sciences Master, 10% owner of ADMA Biologics Inc. (ADMA, Financial), bought 4 million shares for an average price of $4 per share on May 21.

273c5150-7d92-11e9-b73b-15184a5e7c11.png

The biopharmaceutical company has a market cap of $276.43 million and an enterprise value of $315.66 million. It has insider ownership of 0.5% and institutional ownership of 61.16%.

Over the last 12 months, the stock has fallen 12% and is currently trading 33.63% below the 52-week high and 122.12% above the 52-week low.

CEO Randal J. Kirk bought 1.05 million shares of Intrexon Corp (XON, Financial) for an average price of $4.65 per share on May 21.

afc0b810-7d92-11e9-ac2a-d18bcc011f7e.png

The company, which develops synthetic biology solutions, has a market cap of $757.9 million and an enterprise value of $812.01 million. It has insider ownership of 1.25% and institutional ownership of 85.84%.

Over the last 12 months, the stock has fallen 69% and is currently trading 76.40% below the 52-week high and 19.11% above the 52-week low.

Glenn W. Welling, director and 10% owner, and Engaged Capital Co-Invest VI-D bought a combined 3.99 million shares of The Hain Celestial Group Inc. (HAIN, Financial) for an average price of $23.73 per share on May 21.

293d6bc0-7d93-11e9-b943-277280808651.png

The company, which manufactures natural, GMO-free and organic food products, has a market cap of $2.38 billion and an enterprise value of $3.11 billion. It has institutional ownership of 72.74% and an insider ownership of 2.66%.

Over the past 12 months, the stock has fallen 12% and is now trading 27.50% below the 52-week high and 58.20% above the 52-week low

Most important insider sales

Alphaeon Corp., 10% owner of Evolus Inc. (EOLS, Financial), sold 5.30 million shares for an average price of $19.25 per share on May 22.

b7f1d600-7d93-11e9-92e0-196f0287b284.png

The company, which produces medical aesthetic treatments, has a market cap of $462.60 million and an enterprise value of $418.63 million. It has insider ownership of 0.61% and institutional ownership of 26.7%.

Over the last 12 months, the stock has fallen 29%. It is trading 57.77% below the 52-week high and 63.21% above the 52-week low.

John H. Schnatter, founder and 10% owner, sold 3.45 million shares of Papa John's International Inc. (PZZA, Financial) for an average price of $45.63 per share on May 21.

39ec9ef0-7d94-11e9-980c-330d134fb0d6.png

The company has a market cap of $1.49 billion and enterprise value of $1.85 billion. It has insider ownership of 33.33% and institutional ownership of 99.28%.

Over the last 12 months, the stock has fallen 11% and is now trading 22.77% below the 52-week high and 22.92% above the 52-week low.

Orbimed Advisors LLC sold 1 million shares of Principia Biopharma Inc. (PRNB) for an average price of $30.25 per share on May 21.

b84d3b50-7d94-11e9-92f4-73c62fd2711e.png

The biopharmaceutical company has a market cap of $732.46 million, an enterprise value of $568.84 million and an institutional ownership of 94.69%.

Over the last 12 months, the stock has fallen 5%. It is currently trading 19.82% below the 52-week high and 13.43% above the 52-week low.

Disclosure: I do not own any stocks mentioned.

Read more here:

Not a Premium Member of GuruFocus? Sign up for a free 7-day trial here.